SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-07-194072
Filing Date
2007-08-31
Accepted
2007-08-31 15:51:05
Documents
8
Period of Report
2007-08-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 15363
2 SECOND SUPPLEMENTAL INDENTURE dex41.htm EX-4.1 18190
3 THIRD SUPPLEMENTAL INDENTURE dex42.htm EX-4.2 13291
4 FOURTH SUPPLEMENTAL INDENTURE dex43.htm EX-4.3 67998
5 FIFTH SUPPLEMENTAL INDENTURE dex44.htm EX-4.4 203313
6 SECURITIES PURCHASE AGREEMENT dex45.htm EX-4.5 148678
7 FORM OF NOTE ISSUED PURSUANT TO THE SECURITIES PURCHASE AGREEMENT dex46.htm EX-4.6 141436
8 REGISTRATION RIGHTS AGREEMENT dex47.htm EX-4.7 123601
  Complete submission text file 0001193125-07-194072.txt   733272
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23272 | Film No.: 071094546
SIC: 2836 Biological Products, (No Diagnostic Substances)